RT @LaneFoxResearch: Following @LlerWeinreich's RCT evaluating long-term effects of high-flow therapy in stable #COPD patients with chronic…
RT @LaneFoxResearch: Following @LlerWeinreich's RCT evaluating long-term effects of high-flow therapy in stable #COPD patients with chronic…
Following @LlerWeinreich's RCT evaluating long-term effects of high-flow therapy in stable #COPD patients with chronic hypoxaemic respiratory failure (https://t.co/SjRLivx88W): #ERSCongress e-posters on: (1) QoL & Health Economics (2) Qualitative eval
RT @ANZSPMed: A/Prof Smallwood: Nasal high flow therapy provides sustained improvement in breathlessness for COPD patients - and is relativ…
RT @ANZSPMed: A/Prof Smallwood: Nasal high flow therapy provides sustained improvement in breathlessness for COPD patients - and is relativ…
A/Prof Smallwood: Nasal high flow therapy provides sustained improvement in breathlessness for COPD patients - and is relatively well-tolerated! https://t.co/RBU72qAMPv #ANZSPM19 https://t.co/U2QT2UZk4n
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. https://t.co/LoiZ7NzIqD
RT @fphcare: New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl htt…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
RT @fphcare: New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl htt…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
RT @fphcare: New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl htt…
RT @sophiemdanks: Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at ho…
Exciting research looking at the use of #nasalhighflow therapy in the community for #COPD. Using the myAIRVO device at home reduced exacerbation rates. #Optiflow #respiratory https://t.co/tyQLMnKoZR
RT @fphcare: New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl htt…
RT @fphcare: New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl htt…
New research shows use of #nasalhighflow reduces exacerbation rate for #COPD patients @NCBI_PubMed https://t.co/F8sNOoeCEl https://t.co/2IxGw09Eek